RTI Surgical® to Present at the JMP Securities Life Sciences Conference
June 05 2019 - 4:05PM
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical
implant company, today announced that Camille Farhat,
President and Chief Executive Officer, and Jonathon Singer,
Chief Financial and Administrative Officer, are scheduled to
present at the JMP Securities Life Sciences
Conference on Wednesday, June 19, 2019, at
the St. Regis New York at 3:30 p.m. EDT.
A live audio webcast of the conference presentation will be
available online at the investor relations page of the Company’s
website at http://www.rtix.com/en_us/investors/news-events. A
replay of the webcast will be archived on the website for
approximately 90 days.
Molly Poarch Media and Investor Contact
mpoarch@rtix.com +1 224 287 2661
About RTI Surgical Holdings, Inc.
RTI Surgical is a leading global surgical implant company
providing surgeons with safe biologic, metal and synthetic
implants. Committed to delivering a higher standard, RTI’s implants
are used in sports medicine, plastic surgery, spine, orthopedic and
trauma procedures and are distributed in more than 50 countries.
RTI has four manufacturing facilities throughout the U.S. and
Europe. RTI is accredited in the U.S. by the American Association
of Tissue Banks and is a member of AdvaMed. For more information,
please visit www.rtix.com. Connect with us
on LinkedIn and Twitter.
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Sep 2023 to Sep 2024